A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
ConditionPaediatric Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorRuijin Hospital
About this trial
To investigate the feasibility of deep learning-assisted rapid silent PET/MR in pediatric applications.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children who have clinical symptoms and are suspected of having malignant tumors after being evaluated by clinical pediatricians and require 18F-FDG PET/MR examination to further clarify their conditions.
Signed and dated informed consent form
Commit to complying with the research procedures and cooperate in the implementation of the entire research process.
No gender restriction, aged between 0 and 18 years old.
Disqualifiers
Patients with serious illnesses that researchers consider unsuitable for participation in this clinical study. Such as severe heart and lung failure, severe bone marrow suppression, severe liver and kidney dysfunction, etc.
Patients with severe claustrophobia，epileptic seizures, respiratory distress who cannot lie down, and patients with mental anomalies who are unable to cooperate.
Patients with metal implants such as pacemakers, artificial metal heart valves, and neurostimulators in their bodies.
Non-compliant person.
Trial population
Inpatients and outpatients at Ruijin Hospital who meet the inclusion criteria.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
35 Participants
are grouped into 1 trial groupGroup A: Paediatric patients
Trial outcomes
Primary outcomes
1
Lesion detection rate
Routine laboratory or imaging tests or pathology are performed based on clinical needs to assess the accuracy, sensitivity and specificity of rapid silent 18F-FDG PET/MR for lesion detection.
Time frame
1 year2
Completion of PET/MR examinations
Upon completion of the examination, record the rate of completion
Time frame
1 year3
Sedation during PET/MR examinations
Upon completion of the examination, record the rate of sedation and rate of secondary sedation
Time frame
1 year4
Qualitative image quality
Two experienced nuclear medicine physicians evaluated the overall quality of the images using a Likert 5-point scale for both the new imaging PET/MR protocol and the traditional imaging protocol.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov